Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Yahoo Finance referenced a study published in the November 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Prescription Rebate Guarantees: Employer Insights,” examined the role of employer benefits consults and brokers in the selection of pharmacy benefit managers.
An article from Devdiscourse highlighted a study published in the February 2025 issue of AJMC. The study, “Do Localized Disasters Impact Clinical Measures of Health Care Quality?” found that there was no meaningful negative impact of being in a disaster-affected area when it came to Medicare Advantage contract quality performance scores.
An article from LiveAction referenced an article published on AJMC.com, the website of AJMC. The piece, “How Chevron’s Overturn Could Complicate the Health Policy Environment,” explained the possible effects of the Supreme Court’s decision to overturn the Chevron precedent on legislators, agencies, and courts when enforcing health care policies.
An AJMC.com article titled “The Uncertain Road Ahead for Health Care After DEI Rollbacks” was referenced in an article from Healthcare Finance. It covered how the removal of FDA guidance on clinical trial diversity and related policies against diversity, equity, and inclusion efforts could affect health care.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction
April 10th 2025A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Read More
The Future of GI Drug Delivery in Managing IBD
April 10th 2025New drug delivery technologies, such as nanoparticles, hydrogels, and self-powered microgrippers, are showing great potential for enhancing targeted treatment and sustained release of medications in the gastrointestinal (GI) tract, particularly for managing inflammatory bowel disease (IBD).
Read More